WELLINGTON: AFT Pharmaceuticals has signed licensing agreements for its Maxigesic pain relief medication in Germany, Pakistan and Vietnam, countries with pain relief markets worth more than US$1 billion. In Germany, where AFT has already achieved regulatory approval for Maxigesic tablets, the agreement represents the last significant hurdle to making first sales in an analgesic market…